{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:08:20Z","timestamp":1781626100011,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100024743","name":"Suez Canal University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100024743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Contrast-induced acute kidney injury (CI-AKI) is a common complication of coronary angiography and percutaneous coronary interventions, with incidence rates ranging from 1% to 25%. Pre-existing renal impairment is the most significant predisposing factor. L-FABP has been evaluated as a biomarker for CIN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>The aim of this study<\/jats:title>\n                    <jats:p>The aim of this study was early detection of acute kidney injury after coronary angiography by detecting levels of L-FABP as a biomarker to improve the patient\u2019s outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a Pre-post study, as we assessed urinary levels of L-FABP and serum creatinine before and after IV contrast. Sixty-two patients (42 males and 20 females) were recruited from the cardiac catheterization unit of Suez Canal University Hospitals in Ismailia City between December 2021 and January 2022. The study involved medical history, clinical examinations, blood samples for lipid, CBC, creatinine, HbA1C for diabetics, urine L-FABP measurement, and echocardiography. The Mehran score was calculated for each patient to predict risk for CIN and dialysis. Follow-up care for individuals diagnosed with CIN until recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nearly 70% had hypertension (HTN), 48.4% were diabetic, and 16% had CKD. The mean urinary L-FABP pre-contrast was 187.13\u2009\u00b1\u200959.07 ng\/l, and post-contrast was 201.79\u2009\u00b1\u200981.8 ng\/l. The incidence of CIN was 9.7%. urinary L-FABP levels showed a statistically significant difference within the first 6\u00a0h and after 48\u00a0h of contrast injection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, CIN is prevalent in advanced-age patients with higher HbA1c levels in patients undergoing coronary interventions. Post-contrast levels showed a significant difference, suggesting potential for early renal injury detection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-025-04681-4","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:51:15Z","timestamp":1766573475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The utility of urinary liver-binding fatty acid protein levels as a promising biomarker for early detection of acute kidney injury following coronary angiography: a pre-post study at Suez Canal University Hospital"],"prefix":"10.1186","volume":"27","author":[{"given":"Mahytab Moustafa Tolba","family":"Eladrosy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6207-936X","authenticated-orcid":false,"given":"Mohamed Salah","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7467-9210","authenticated-orcid":false,"given":"Omar Mohamed","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5889-3791","authenticated-orcid":false,"given":"Hanan Hassan","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-9644","authenticated-orcid":false,"given":"Basma Osman","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"4681_CR1","doi-asserted-by":"crossref","unstructured":"Campion D, Ponzo P, Risso A, Caropreso P, Caviglia GP, Sanavia T, et al. A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis. J Hepatol. 2024;80(1):62\u201372.","DOI":"10.1016\/j.jhep.2023.10.010"},{"key":"4681_CR2","doi-asserted-by":"crossref","unstructured":"Zdziechowska M, Gluba-Brz\u00f3zka A, Poliwczak AR, Franczyk B, Kidawa M, Zielinska M, et al. Serum NGAL, KIM-1, IL-18, L-FABP: new biomarkers in the diagnostics of acute kidney injury (AKI) following invasive cardiology procedures. Int Urol Nephrol. 2020;52:2135\u201343.","DOI":"10.1007\/s11255-020-02530-x"},{"key":"4681_CR3","doi-asserted-by":"crossref","unstructured":"Li Q, Pan SJIJGM. Contrast-associated acute kidney injury: advances and challenges. Int J Gen Med. 2022;15:1537\u201346.","DOI":"10.2147\/IJGM.S341072"},{"key":"4681_CR4","doi-asserted-by":"crossref","unstructured":"Chaudhari H, Mahendrakar S, Baskin SE, Reddi ASJIJN, Disease R. Contrast-induced acute kidney injury: evidence in support of its existence and a review of its pathogenesis and management. Int J Nephrol Renovasc Dis. 2022;15:253\u201366.","DOI":"10.2147\/IJNRD.S371700"},{"key":"4681_CR5","doi-asserted-by":"crossref","unstructured":"Connolly M, Kinnin M, McEneaney D, Menown I, Kurth M, Lamont J, et al. Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography. QJM: Int J Med. 2018;111(2):103\u201310.","DOI":"10.1093\/qjmed\/hcx201"},{"key":"4681_CR6","doi-asserted-by":"crossref","unstructured":"Lu Y-C, Chang C-C, Wang C-P, Hung W-C, Tsai I-T, Tang W-H, et al. Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Int J Med Sci. 2020;17(2):182.","DOI":"10.7150\/ijms.40417"},{"key":"4681_CR7","doi-asserted-by":"crossref","unstructured":"Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki SJAMS. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine. Adv Med Sci. 2009;54(2):221\u20134.","DOI":"10.2478\/v10039-009-0036-1"},{"key":"4681_CR8","doi-asserted-by":"crossref","unstructured":"Manabe K, Kamihata H, Motohiro M, Senoo T, Yoshida S, Iwasaka TJE. Urinary liver-type fatty acid\u2010binding protein level as a predictive biomarker of contrast\u2010induced acute kidney injury. Eur J Clin Invest. 2012;42(5):557\u201363.","DOI":"10.1111\/j.1365-2362.2011.02620.x"},{"key":"4681_CR9","doi-asserted-by":"crossref","unstructured":"Soliman AR, Yosry A, Samir HH, Abdelaziz T, Soliman H, Ahmed RMJOAMJMS. Novel urinary biomarkers and chronic kidney disease after coronary angiography: a prospective case-controlled study. Open Access Maced J Med Sci. 2020;8(B):1029\u201335.","DOI":"10.3889\/oamjms.2020.4857"},{"issue":"2","key":"4681_CR10","first-page":"e293","volume":"172","author":"N Okumura","year":"2014","unstructured":"Okumura N, Hayashi M, Ishii H, Yoshikawa D, Yasuda Y, Goto M, et al. Novel preprocedural and acute-phase postprocedural predictive factors for contrast-induced kidney injury in CKD Patients. Int J Cardiol. 2014;172(2):e293\u20136.","journal-title":"CKD Patients"},{"issue":"7","key":"4681_CR11","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.3390\/ijms26072869","volume":"26","author":"P-H Lee","year":"2025","unstructured":"Lee P-H, Huang SM, Tsai Y-C, Wang Y-T, Chew FY. Biomarkers in contrast-induced nephropathy: advances in early detection, risk assessment, and prevention strategies. Int J Mol Sci. 2025;26(7):2869.","journal-title":"Int J Mol Sci"},{"key":"4681_CR12","doi-asserted-by":"crossref","unstructured":"Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393\u20139.","DOI":"10.1016\/S0735-1097(04)01445-7"},{"issue":"1","key":"4681_CR13","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.4037\/ccn2011746","volume":"31","author":"B Raingruber","year":"2011","unstructured":"Raingruber B, Kirkland-Walsh H, Chahon N, Kellermann M. Using the Mehran risk scoring tool to predict risk for contrast medium\u2013induced nephropathy in patients undergoing percutaneous angiography. Crit Care Nurse. 2011;31(1):e17\u201322.","journal-title":"Crit Care Nurse"},{"key":"4681_CR14","doi-asserted-by":"crossref","unstructured":"Liu X, Zhang P, Zhang J, Zhang X, Yang S, Fu NJA. The preventive effect of alprostadil on the contrast-induced nephropathy of coronary heart disease treated by percutaneous coronary intervention in moderate and high-risk population stratified by Mehran score. Angiology. 2022;73(1):33\u201341.","DOI":"10.1177\/00033197211015540"},{"key":"4681_CR15","doi-asserted-by":"crossref","unstructured":"Shuka N, Kristo A, Gishto T, Simoni L, Hasimi E, Shirka E, et al. Contrast induced nephropathy in interventional cardiology; identification of high-risk patients and its prevention. Eur J Prev Cardiol. 2022;29(Supplement_1):zwac056-078.","DOI":"10.1093\/eurjpc\/zwac056.078"},{"key":"4681_CR16","doi-asserted-by":"crossref","unstructured":"He H, Chen X-R, Chen Y-Q, Niu T-S, Liao Y-MJJIC. Prevalence and predictors of contrast-induced nephropathy (CIN) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI): a meta-analysis. J Interv Cardiol. 2019;2019(1):2750173.","DOI":"10.1155\/2019\/2750173"},{"key":"4681_CR17","unstructured":"\u00c7etin M, Acehan F, Kundi H, Yakici I, Katipoglu B, Duran G, et al. A novel risk prediction tool for contrast-induced nephropathy in patients with chronic kidney disease who underwent diagnostic coronary angiography. Eur Rev Med Pharmacol Sci. 2023;27(8)."},{"key":"4681_CR18","doi-asserted-by":"crossref","unstructured":"Yuksel Y, Kose SJA. Prognostic nutritional index predicts contrast-induced nephropathy in patients with acute coronary syndrome. Angiology. 2023;74(8):736\u201344.","DOI":"10.1177\/00033197221116203"},{"key":"4681_CR19","doi-asserted-by":"crossref","unstructured":"Abdel-Ghany M, Morsy G, Kishk YTJTEJIM. Predictors of contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Egypt J Intern Med. 2021;33(1):16.","DOI":"10.1186\/s43162-021-00043-2"},{"key":"4681_CR20","doi-asserted-by":"crossref","unstructured":"Ba\u011fc\u0131 A, Aksoy F, Ba\u015f HAJA. Systemic immune-inflammation index May predict the development of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology. 2022;73(3):218\u201324.","DOI":"10.1177\/00033197211030053"},{"key":"4681_CR21","doi-asserted-by":"crossref","unstructured":"Kewcharoen J, Yi R, Trongtorsak A, Prasitlumkum N, Mekraksakit P, Vutthikraivit W, Kanjanauthai SJCRM. Pre-procedural hyperglycemia increases the risk of contrast-induced nephropathy in patients undergoing coronary angiography: a systematic review and meta-analysis. Cardiovasc Revasc Med. 2020;21(11):1377\u201385.","DOI":"10.1016\/j.carrev.2020.04.040"},{"key":"4681_CR22","doi-asserted-by":"crossref","unstructured":"Yildiz I, Yildiz PO, Rencuzogullari I, Karabag Y, Cagdas M, Burak C, Gurevin MSJA. Association of serum osmolarity with contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology. 2019;70(7):627\u201332.","DOI":"10.1177\/0003319719826466"},{"key":"4681_CR23","doi-asserted-by":"crossref","unstructured":"\u015eayl\u0131k F, \u00c7\u0131nar T, Sar\u0131kaya R, Tanbo\u011fa \u0130HJA. Development and validation of nomogram based on the systemic-immune inflammation response index for predicting contrast-induced nephropathy in ST-elevation myocardial infarction patients. Angiology. 2024;75(7) 673\u201381.","DOI":"10.1177\/00033197231191429"},{"key":"4681_CR24","doi-asserted-by":"crossref","unstructured":"\u00d6zdemir E, Ak\u00e7ay FA, Esen S, Emren SV, Karaca M, Nazl\u0131 C, K\u0131r\u0131\u015f TJA. Predictive value of the modified Mehran score for contrast-induced nephropathy after transcatheter aortic valve implantation. Angiology. 2024;75(3):267\u201373.","DOI":"10.1177\/00033197231151269"},{"key":"4681_CR25","doi-asserted-by":"crossref","unstructured":"Wu M-Y, Lo W-C, Wu Y-C, Lin T-C, Lin C-H, Wu M-S, Tu Y-KJFM. The incidence of contrast-induced nephropathy and the need of dialysis in patients receiving angiography: a systematic review and meta-analysis. Front Med. 2022;9:862534.","DOI":"10.3389\/fmed.2022.862534"},{"key":"4681_CR26","doi-asserted-by":"crossref","unstructured":"Kumar R, Ahmed T, Khatti S, Memon A-uR, Shaikh NA, Farooq F, et al. Validity of Mehran risk score for predicting contrast induced nephropathy in modern primary percutaneous coronary interventions era. Pak Heart J. 2022;55(1):73\u20138.","DOI":"10.47144\/phj.v55i1.2183"},{"issue":"9Supplement","key":"4681_CR27","first-page":"842","volume":"79","author":"AJ Mirza","year":"2022","unstructured":"Mirza AJ, Gao C, Ali K, Bell S, Lambourg E, Mordi I, et al. Pre-procedural risk scores to help identify patients at risk of contrast induced nephropathy after chronic total occlusion percutaneous coronary intervention for Peri-procedural. Nephroprotective Ther. 2022;79(9Supplement):842.","journal-title":"Nephroprotective Ther"},{"key":"4681_CR28","doi-asserted-by":"crossref","unstructured":"Peabody J, Paculdo D, Valdenor C, McCullough PA, Noiri E, Sugaya T, Dahlen JRJCM. Clinical utility of a biomarker to detect contrast-induced acute kidney injury during percutaneous cardiovascular procedures. Cardiorenal Med. 2022;12(1):11\u20139.","DOI":"10.1159\/000520820"},{"key":"4681_CR29","doi-asserted-by":"crossref","unstructured":"Lin J, Chen J, Wu D, Li X, Guo X, Shi S, et al. Biomarkers for the early prediction of contrast-induced nephropathy after percutaneous coronary intervention in adults: a systematic review and meta-analysis. Angiology. 2022;73(3):207\u201317.","DOI":"10.1177\/00033197211039921"},{"key":"4681_CR31","doi-asserted-by":"crossref","unstructured":"Pan H-C, Yang S-Y, Chiou TT-Y, Shiao C-C, Wu C-H, Huang C-T, et al. Comparative accuracy of biomarkers for the prediction of hospital-acquired acute kidney injury: a systematic review and meta-analysis. Crit Care. 2022;26(1):1\u201330.","DOI":"10.1186\/s13054-022-04223-6"},{"issue":"1","key":"4681_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/10408363.2023.2242481","volume":"61","author":"A Rossiter","year":"2024","unstructured":"Rossiter A, La A, Koyner JL, Forni LG. New biomarkers in acute kidney injury. Crit Rev Clin Lab Sci. 2024;61(1):23\u201344.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"4681_CR33","doi-asserted-by":"crossref","unstructured":"Yousef Almulhim M. The efficacy of novel biomarkers for the early detection and management of acute kidney injury: a systematic review. PLoS One. 2025 Jan 29;20(1).","DOI":"10.1371\/journal.pone.0311755"},{"issue":"1","key":"4681_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12882-025-04040-3","volume":"26","author":"H Yang","year":"2025","unstructured":"Yang H, Chen Y, He J, Li Y, Feng Y. Advances in the diagnosis of early biomarkers for acute kidney injury: a literature review. BMC Nephrol. 2025;26(1):115.","journal-title":"BMC Nephrol"},{"key":"4681_CR35","doi-asserted-by":"crossref","unstructured":"Wybraniec MT, Chudek J, Bo\u017centowicz-Wikarek M, Mizia\u2010Stec KJJ. Prediction of contrast\u2010induced acute kidney injury by early post\u2010procedural analysis of urinary biomarkers and intra\u2010renal doppler flow indices in patients undergoing coronary angiography. J Interv Cardiol. 2017;30(5):465\u201372.","DOI":"10.1111\/joic.12404"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04681-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04681-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04681-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:45:56Z","timestamp":1781624756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04681-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4681"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04681-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved at 25\/10\/2021 by the local Medical Ethics Committees of the Faculty of Medicine, Suez Canal University, Ismailia, Egypt (Approval number: 4670). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Verbal and written informed consents were obtained from all individual participants included in the study before the interview.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data was collected and coded, then analyzed using the Statistical Package for the Social Sciences (SPSS) program version 22.0.0.0. Data was presented as tables and graphs as appropriate. Continuous variables were expressed as mean and standard deviation, while categorical variables were expressed as numbers (N) and percentages (%). Comparisons were performed using the T-test (for quantitative data) and chi-squared-test (\u03c72), or Fisher\u2019s Exact test was used (for qualitative data). One-way analysis of variance (ANOVA) was used for parametric variables, and the Kruskal-Wallis test was used for non-parametric variables.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistical analysis"}},{"value":"We declare the use of Grammarly as a tool for language editing and improving readability.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}